Screener
Sarepta Therapeutics, Inc. SRPT Operating margin
Discontinued — last reported Q2 '23
Operating margin at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 7, 2024. Open the filing →
- Filed
- Aug 7, 2024
- Fiscal quarter
- Q2 FY2024
- Calendar quarter
- Q2 2024
- Accession
- 0000950170-24-092720
FAQ
- What is Sarepta Therapeutics, Inc.'s operating margin?
- Sarepta Therapeutics, Inc. (SRPT) reported operating margin of -50.8% in Q2 2023.
- How has Sarepta Therapeutics, Inc.'s operating margin changed year-over-year?
- Sarepta Therapeutics, Inc.'s operating margin increased by 3.2% year-over-year, from -52.5% to -50.8%.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s operating margin?
- Over 2 years (2020 to 2022), Sarepta Therapeutics, Inc.'s operating margin has grown at a -25.8% compound annual growth rate (CAGR), from -104.5% to -57.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Sarepta Therapeutics, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude